Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2021-07-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Different Preoperative Decision Schemes on the Visual Quality After Toric Intraocular Lens Implantation
NCT04006912
Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation
NCT03059043
Safety and Efficacy of Implantable Collamer Lens Versus Implantable Phakic Lens IPCL in Myopic Patients; A Comparative Study
NCT06058780
Visual Performance With a Trifocal Intraocular Lens
NCT01605058
Safety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDs
NCT06371079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preoperative corneal endothelial cell count ≥2200/mm2
* Preoperative central anterior chamber depth\> 2.80mm
* Intraocular pressure within the normal range (10-21mmHg)
Exclusion Criteria
* Cataract and glaucoma
* Patients with uveitis
* Retinal detachment
* Patients with autoimmune diseases
* Patients with systemic diseases such as diabetes and hypertension
* Patients with mental or cognitive abnormalities
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
He Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei He
Role: STUDY_CHAIR
He Eye Specialist Hospital, Shenyang.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
He Eye Specialist Hospital, Shenyang.
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICL2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.